Kempisty Anna, Lewandowska Anna, Kuś Jan
1st Department of Lung Diseases, Institute of Tuberculosis and Lung Diseases, Warsaw, Poland.
Pol Merkur Lekarski. 2018 Mar 27;44(261):147-149.
The role of vitamin D in the human body is not limited only to the regulation of calcium metabolism and secondary to the impact on bones. Recent studies have shown the influence of vitamin D level on muscles, on the risk of cancer, diabetes, hypertension and pulmonary diseases, including granulomatous diseases. Sarcoidosis is a granulomatous disease of unknown etiology. Hypercalcemia in the course of the disease occurs in up to 10% of cases in the consequence of autonomous overproduction of 1,25-dihydroxyvitamin D by macrophages of sarcoid granulomas. Hypercalciuria occurs 3-fold more frequent. On the other hand, treatment with corticosteroids increases the risk of osteoporosis. Vitamin D intake is recommended for prevention of osteoporosis. Such management, in sarcoidosis patients, is not so clear because of risk of hypercalcemia. Vitamin D supplementation, according to current recommendations for general population, is based solely on 25-hydroxyvitamin D level testing. This seems to be not safe in the group of sarcoidosis patients. This article discusses the role of vitamin D in sarcoidosis patients and current opinion on vitamin D supplementation in this group.
维生素D在人体中的作用不仅限于调节钙代谢以及对骨骼的继发影响。最近的研究表明,维生素D水平对肌肉、患癌症、糖尿病、高血压和肺部疾病(包括肉芽肿性疾病)的风险有影响。结节病是一种病因不明的肉芽肿性疾病。在该疾病过程中,高达10%的病例会因结节病肉芽肿的巨噬细胞自主过量产生1,25 - 二羟基维生素D而出现高钙血症。高钙尿症的发生频率则高出3倍。另一方面,使用皮质类固醇进行治疗会增加骨质疏松症的风险。建议摄入维生素D以预防骨质疏松症。然而,对于结节病患者而言,由于存在高钙血症风险,这种管理方式并不明确。根据目前针对普通人群的建议,维生素D补充仅基于25 - 羟基维生素D水平检测。这在结节病患者群体中似乎并不安全。本文讨论了维生素D在结节病患者中的作用以及目前关于该群体维生素D补充的观点。